BMS-303141
BMS303141 is a potent inhibitor of ATP citrate lyase (ACL) . BMS-303141 inhibits lipid synthesis in HepG2 cells with an IC50 of 8 μM, and lowers plasma triglycerides in a murine hyperlipdemia model.
Product Specifications
CAS Number
943962-47-8
Product Name Alternative
BMS303141 | BMS-303141 | BMS 303141
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 47 mg/mL; 110.77 mM
Smiles
C1c (cccc1) c1cc (c (cc1) OC) NS (=O) (=O) c1c (O) c (cc (c1) Cl) Cl
Molecular Formula
C19H15Cl2NO4S
Molecular Weight
424.3
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
3,5-Dichloro-2-hydroxy-N- (4-methoxy[1,1′-biphenyl]-3-yl) -benzenesulfonamide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![7- (2-chlorobutyl) -8-[ (2-hydroxyethyl) amino]-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
OR22687 1 Each
7- (2-chlorobutyl) -8-[ (2-hydroxyethyl) amino]-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
Sign In for Pricing
View Details 
MBS2124421-01 0.01 mg
Recombinant Vascular Endothelial Growth Factor D (VEGFD)
Sign In for Pricing
View Details MBS2124421-02 0.05 mg
Recombinant Vascular Endothelial Growth Factor D (VEGFD)
Sign In for Pricing
View Details